BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15611441)

  • 1. Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.
    Nori S; Nebesio C; Brashear R; Travers JB
    Arch Dermatol; 2004 Dec; 140(12):1537-8. PubMed ID: 15611441
    [No Abstract]   [Full Text] [Related]  

  • 2. Moxifloxacin--a new fluoroquinolone antibacterial.
    Drug Ther Bull; 2004 Aug; 42(8):61-2. PubMed ID: 15310155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.
    Weaver CH; Huddleston HM; Kingsley MM; Wolverton SE
    J Drugs Dermatol; 2009 Nov; 8(11):1031-3. PubMed ID: 19894372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin-associated drug hypersensitivity syndrome with drug-induced hypersensitivity pneumonitis.
    Son CH; Kim HI; Kim KN; Lee KN; Lee CU; Roh MS; Kim KH; Yang DK; Lee SK
    J Investig Allergol Clin Immunol; 2008; 18(1):72-3. PubMed ID: 18361108
    [No Abstract]   [Full Text] [Related]  

  • 5. Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature.
    Chang B; Knowles SR; Weber E
    Ann Pharmacother; 2010 Apr; 44(4):740-5. PubMed ID: 20233910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal pristinamycin-induced toxic epidermal necrolysis (Lyell's syndrome): difficulties in attributing causal association in the polymedicated intensive care unit patient.
    Chanques G; Girard C; Pinzani V; Jaber S
    Acta Anaesthesiol Scand; 2005 May; 49(5):721-2. PubMed ID: 15836693
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects and safety of antimicrobial agents--allergy].
    Ikezawa Z
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():578-86. PubMed ID: 17455685
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic anaphylaxis caused by moxifloxacin.
    Sánchez-Morillas L; Rojas Pérez-Ezquerra P; Reaño-Martos M; Laguna-Martínez JJ; Gómez-Tembleque P
    Allergol Immunopathol (Madr); 2010; 38(4):226-7. PubMed ID: 20089346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug toxicodermias].
    Korolev IuF
    Vestn Dermatol Venerol; 1980 Oct; (10):26-32. PubMed ID: 6449790
    [No Abstract]   [Full Text] [Related]  

  • 10. A fatal case of toxic epidermal necrolysis with extensive intestinal involvement.
    Kedward AL; McKenna K
    Clin Exp Dermatol; 2009 Oct; 34(7):e484. PubMed ID: 19747323
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe acute polyarthritis in a child after high doses of moxifloxacin.
    Torres JR; Bajares A
    Scand J Infect Dis; 2008; 40(6-7):582-4. PubMed ID: 18584553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal adverse drug reaction to trimethoprim.
    Mortimer NJ; Bermingham MR; Chapple SJ; Sladden MJ
    Aust Fam Physician; 2005 May; 34(5):345-6. PubMed ID: 15887936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute epidermal necrolysis (Lyell's syndrome) in a female patient with autoimmune thyroiditis].
    Chebotarev KS; Polianko NI; Kunakov IuI
    Vestn Dermatol Venerol; 1989; (8):56-8. PubMed ID: 2816033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxifloxacin as the likely cause of drug-induced linear immunoglobulin A bullous dermatosis.
    Kovacic D; Fox M; Reichenberg J
    J Drugs Dermatol; 2008 Aug; 7(8):794-5. PubMed ID: 18720700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin-induced fatal toxic epidermal necrolysis.
    Islam AF; Rahman MS
    Ann Pharmacother; 2005 Jun; 39(6):1136-7. PubMed ID: 15886293
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics of Lyell's syndrome caused by drug hypersensitivity].
    Severova EIa; Minosian AT
    Sov Med; 1983; (4):25-9. PubMed ID: 6867829
    [No Abstract]   [Full Text] [Related]  

  • 17. Toxic epidermal necrolysis after hepatic transplantation.
    Ostlere LS; Harris D; Burroughs AK; Rolles K
    Arch Dermatol; 1992 Nov; 128(11):1550-1. PubMed ID: 1444516
    [No Abstract]   [Full Text] [Related]  

  • 18. Moxifloxacin-associated neutropenia.
    Berk V; Demiraslan H; Berk E; Karaca H; Inanc M; Bozkurt O; Ozkan M
    Scand J Infect Dis; 2013 May; 45(5):415-6. PubMed ID: 23151058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moxifloxacin and hepatic toxicity].
    Franco Hidalgo S; Prieto de Paula JM; García Lorenzo R; Salado Valdivieso I
    Gastroenterol Hepatol; 2009 Dec; 32(10):719-20. PubMed ID: 19664854
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fatal outcome in allopurinol hypersensitivity syndrome].
    Kluger E
    Ugeskr Laeger; 1998 Feb; 160(8):1179-80. PubMed ID: 9492630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.